New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
08:36 EDTCRIGoldman says to buy Carter's ahead of margin inflection
Goldman said there has been a positive inflection in live births in the U.S. for the first time since 2007 and said Carter's is the most leveraged to improving birth trends. The analyst recommends buying Carter's ahead of strong organic growth and margin improvement. Shares are Buy rated with a $102 price target.
News For CRI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 1, 2015
10:00 EDTCRIOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Autoliv (ALV) downgraded to Underperform from Outperform at Exane BNP Paribas... Baxter (BAX) downgraded to Neutral from Outperform at Credit Suisse... Carter's (CRI) downgraded to Buy from Conviction Buy at Goldman... Fiat Chrysler (FCAU) downgraded to Neutral from Outperform at Exane BNP Paribas... H&E Equipment (HEES) downgraded to Sector Weight from Overweight at KeyBanc... L'Oreal (LRLCY) downgraded to Sell from Neutral at Citi... Marchex (MCHX) downgraded to Equal Weight from Overweight at Stephens... NASDAQ (NDAQ) downgraded to Market Perform from Outperform at Keefe Bruyette... Starbucks (SBUX) downgraded to Buy from Conviction Buy at Goldman... Towers Watson (TW) downgraded to Hold from Buy at Deutsche Bank... Tuesday Morning (TUES) downgraded to Accumulate from Buy at Johnson Rice... United Rentals (URI) downgraded to Sector Weight from Overweight at KeyBanc.
07:24 EDTCRICarter's downgraded to Buy from Conviction Buy at Goldman
Goldman removed Carter's from the Conviction Buy List following the recent run in shares. The firm maintains its Buy rating and increased its price target to $127 from $115.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use